U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755904) titled 'BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy' on Aug. 05.
Brief Summary: The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy (oHCM). The trial includes adults who are currently being treated for oHCM or who have not yet been treated.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Cardiomyopathy, Hypertrophic Obstructive
Intervention:
DRUG: BHB-1893
Tablets for oral use
DRUG: Metoprolol
Capsules for oral use
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Brave...